For wound Debridement
- UID
- IMP/MD/2019/000547_1858772d9e163a944c336528df349b1e_a39065285df9b138edf9648ae02df1ba
- Device class
- Class C
- Brand name
- Debrisoft® Lolly
- License holder
- Genetix Biotech Asia Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- Debrisoft® Lolly is intended for the debridement of deep – including surgically invasive – to superficial wounds for wound bed preparation e.g., diabetic ulcers, arterial and venous ulcers, pressure ulcers, postoperative wounds healing by secondary intention and trauma as well as burns / scalds. Debrisoft® Lolly can also be used to absorb exudate, debris and keratodermas during debridement.
For wound Debridement is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000547_1858772d9e163a944c336528df349b1e_a39065285df9b138edf9648ae02df1ba. This device is marketed under the brand name Debrisoft® Lolly. The license holder is Genetix Biotech Asia Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.